Results 61 to 70 of about 41,531 (223)
Objectives: Linezolid is a last-resort antimicrobial in human clinical settings to treat multidrug-resistant Gram-positive bacterial infections. Mobile linezolid resistance genes (optrA, poxtA, and cfr) have been detected in various sources worldwide ...
Akira Fukuda +3 more
doaj +1 more source
ABSTRACT Objectives To describe the aetiology and antibiotic susceptibility patterns of common bacterial infections in hospitalised patients in Jakarta, Indonesia. Methods We conducted a hospital‐wide point prevalence survey in six hospitals in 2019, capturing data from routinely ordered bacterial cultures taken before the start of antibiotic treatment.
Justin de Brabander +36 more
wiley +1 more source
Prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States
ABSTRACT Background Antimicrobial resistance is a critical global health concern driven by antimicrobial use. Dermatological conditions are common reasons for antimicrobial prescriptions in small animal practice, yet data on prescribing patterns in veterinary dermatology referral settings are lacking. Hypothesis/Objectives To characterise the frequency,
Domenico Santoro +2 more
wiley +1 more source
Linezolid, an oxazolidinone antibiotic effective against Gram-positive pathogens, may cause nephrotoxicity and lactic acidosis during prolonged therapy. This experimental study investigated the protective effects of adenosine triphosphate (ATP), thiamin,
Ozlem Admis +7 more
doaj +1 more source
Abstract figure legend A study described in this paper describes a new tool for hiPSC‐CM electromechanical behaviour simulations using mathematical modelling. The model enables in silico assays making drug testing quick, comprehensive and accurate. New hiPSC‐CM models can be used as a platform to integrate in vitro and in silico findings.
Milda Folkmanaite +9 more
wiley +1 more source
Efficacy of linezolid in the treatment of tuberculous meningitis: a meta-analysis
Introduction Tuberculous meningitis (TBM) is a severe extra-pulmonary tuberculosis with high fatality. This meta-analysis aimed to assess the impact of linezolid on TBM treatment outcomes.
Jian-Qing He +3 more
core +1 more source
Abstract figure legend A mechanistic framework linking sex‐dependent dynamical instability to proarrhythmic risk. Sex‐specific human ventricular models show that upstream modulators, including biological sex, hormones, drugs and heart disease, promote steeper APD restitution in female than male and enhance dynamical instability.
Daisuke Sato +3 more
wiley +1 more source
Antimicrobial agents against vancomycin-resistant enterocci (Linezolid)
Linezolid(LZD)は米国ファルマシア・アップジョン社で合成されたoxazolidinone 骨格を有する薬剤であり,30 年ぶりに新しい分類に属する抗菌薬として開発されている。LZD は50 S サブユニットのドメインV に特異的に結合することにより,50 S リボゾーム,30 S リボゾーム,m.RNA およびf.Met.t.RNA からなる開始複合体の形成を阻害する。その結果,既存の抗菌薬と異なり,蛋白合成の開始を抑制することにより抗菌力を発揮する。LZD は,メチシリン耐性黄色ブドウ球菌(
壼原, 克紀, 河野, 茂
core
Jieyun Huang,1,* Zhi Chen,2,* Ying Li,3 Li Li,2 Guangyu Zhang2 1The Second Clinical Medical College, Shanxi Medical University, Taiyuan, People’s Republic of China; 2Institute for Tuberculosis Research, The 309th Hospital of Chinese PLA, Beijing ...
Zhang G +9 more
core +1 more source
Abstract Introduction Linezolid, a synthetic oxazolidinone for resistant gram‐positive infections, is generally associated with mild adverse effects such as gastrointestinal disturbances, but more serious reactions like lactic acidosis (LA) have also been reported.
Lina Naseralallah +4 more
wiley +1 more source

